Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

VERRICA PHARMACEUTICALS INC.

(VRCA)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/19/2021 07/20/2021 07/21/2021 07/22/2021 07/23/2021 Date
10.54(c) 11.44(c) 11.5(c) 10.92(c) 10.57(c) Last
33 094 87 158 55 843 30 896 33 564 Volume
+2.53% +8.54% +0.52% -5.04% -3.21% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 15,5 M - -
Net income 2021 -42,0 M - -
Net Debt 2021 - - -
P/E ratio 2021 -7,39x
Yield 2021 -
Sales 2022 36,8 M - -
Net income 2022 -59,4 M - -
Net Debt 2022 - - -
P/E ratio 2022 -6,07x
Yield 2022 -
Capitalization 290 M 290 M -
Capi. / Sales 2021 18,6x
Capi. / Sales 2022 7,88x
Nbr of Employees 29
Free-Float 35,6%
More Financials
Company
Verrica Pharmaceuticals Inc. is a United States-based clinical-stage medical dermatology company. The Company is focused on identifying, developing and commercializing pharmaceutical products for the treatment of skin diseases with unmet needs. Its lead product candidate, VP-102, is a drug-device combination of topical solution of cantharidin. The Company also intends to develop second cantharidin-based product... 
Sector
Pharmaceuticals
Calendar
08/11Earnings Release
More about the company
Ratings of Verrica Pharmaceuticals Inc.
Trading Rating : 
Investor Rating :  -
ESG Refinitiv : 
D
More Ratings
All news about VERRICA PHARMACEUTICALS INC.
07/12VERRICA PHARMACEUTICALS INC : . announced the appointment of Terry Kohler as Chi..
AQ
07/12VERRICA PHARMACEUTICALS : Announces Appointment of Terry Kohler as Chief Financi..
AQ
07/09VERRICA PHARMACEUTICALS INC. : Change in Directors or Principal Officers (form 8..
AQ
07/09VERRICA PHARMACEUTICALS : Names Terry Kohler Finance Chief
MT
07/09VERRICA PHARMACEUTICALS : Announces Appointment of Terry Kohler as Chief Financi..
AQ
07/09Verrica Pharmaceuticals Announces Appointment of Terry Kohler as Chief Financ..
CI
06/21Certain Common Stock of Verrica Pharmaceuticals Inc. are subject to a Lock-Up..
CI
06/21Certain Stock Options of Verrica Pharmaceuticals Inc. are subject to a Lock-U..
CI
06/21Certain Restricted Stock Units of Verrica Pharmaceuticals Inc. are subject to..
CI
06/10VERRICA PHARMACEUTICALS INC. : Submission of Matters to a Vote of Security Holde..
AQ
06/03SHAREHOLDER ALERT : Pomerantz Law Firm Investigates Claims On Behalf of Investor..
PR
06/01VERRICA PHARMACEUTICALS : Northland Adjusts Price Target on Verrica Pharmaceutic..
MT
05/31VERRICA PHARMACEUTICALS : Company Presentation
PU
05/31VERRICA PHARMACEUTICALS : Announces Extension of FDA Review Period of its NDA fo..
AQ
05/28VERRICA PHARMACEUTICALS : Announces Extension of FDA Review Period of its NDA fo..
PU
More news
News in other languages on VERRICA PHARMACEUTICALS INC.

- No features available -

More news
Analyst Recommendations on VERRICA PHARMACEUTICALS INC.
More recommendations
Chart VERRICA PHARMACEUTICALS INC.
Duration : Period :
Verrica Pharmaceuticals Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends VERRICA PHARMACEUTICALS INC.
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Last Close Price 10,57 $
Average target price 21,50 $
Spread / Average Target 103%
EPS Revisions
Managers and Directors
Ted White President, Chief Executive Officer & Director
A. Brian Davis CFO & Principal Accounting Officer
Paul B. Manning Chairman
Gary Goldenberg Chief Medical Officer
Eugene Scavola Executive Vice President-Technical Operations
Sector and Competitors
1st jan.Capi. (M$)
VERRICA PHARMACEUTICALS INC.-8.17%313
JOHNSON & JOHNSON9.16%432 430
ROCHE HOLDING AG11.02%325 975
PFIZER, INC.13.23%218 198
ELI LILLY AND COMPANY44.60%209 276
NOVARTIS AG0.20%207 246